SEC Form 10-Q filed by JetBlue Airways Corporation
10-Q - JETBLUE AIRWAYS CORP (0001158463) (Filer)
Live Feed
Delayed 3mPress · Analyst · SEC · Financials · Leadership Updates
Signed out · 3-min delay · Sign up for real-time
- Shutterstock Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Shutterstock, Inc. (0001549346) (Filer)
- SEC Form 144 filed by Nano Dimension Ltd.
144 - Nano Dimension Ltd. (0001643303) (Subject)
- Canaccord Genuity initiated coverage on Lineage Cell Therapeutics with a new price target
Canaccord Genuity initiated coverage of Lineage Cell Therapeutics with a rating of Buy and set a new price target of $9.00
- Xylem Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Xylem Inc. (0001524472) (Filer)
- Asbury Automotive Group Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - ASBURY AUTOMOTIVE GROUP INC (0001144980) (Filer)
- Galaxy Digital Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Galaxy Digital Inc. (0001859392) (Filer)
- Incyte Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - INCYTE CORP (0000879169) (Filer)
- Axogen Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Axogen, Inc. (0000805928) (Filer)
- Corning Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - CORNING INC /NY (0000024741) (Filer)
- JetBlue Airways Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - JETBLUE AIRWAYS CORP (0001158463) (Filer)
- SEC Form 20-F filed by Jinxin Technology Holding Company
20-F - Jinxin Technology Holding Co (0001967631) (Filer)
- Shutterstock Reports First Quarter 2026 Financial Results
NEW YORK, April 28, 2026 /PRNewswire/ -- Shutterstock, Inc. (NYSE:SSTK) (the "Company"), a family of brands delivering scalable creative and GenAI solutions to help customers fuel great work, today announced financial results for the first quarter ended March 31, 2026. Commenting on the Company's performance, Paul Hennessy, the Company's Chief Executive Officer, said, "During the first quarter, we maintained a strong focus on operational discipline and cost management, delivering $43 million in Adjusted EBITDA in the face of ongoing industry headwinds. While first quarter revenu
- Hello Group Files Annual Report on Form 20-F for Fiscal Year 2025
BEIJING, April 28, 2026 /PRNewswire/ -- Hello Group Inc. (NASDAQ:MOMO) ("Hello Group" or the "Company"), a leading player in Asia's online social networking space, today filed with the U.S. Securities and Exchange Commission its annual report on Form 20-F for the fiscal year ended December 31, 2025. The annual report can be accessed on the Company's investor relations website at https://ir.hellogroup.com/ or on the SEC's website at https://www.sec.gov. The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to the Company's Investors Relati
- SEC Form 20-F filed by Jiayin Group Inc.
20-F - Jiayin Group Inc. (0001743102) (Filer)
- SEC Form DEFA14A filed by Ocugen Inc.
DEFA14A - Ocugen, Inc. (0001372299) (Filer)
- CECO Environmental Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - CECO ENVIRONMENTAL CORP (0000003197) (Filer)
- SEC Form 10-Q filed by reAlpha Tech Corp.
10-Q - reAlpha Tech Corp. (0001859199) (Filer)
- Avalo Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Avalo Therapeutics, Inc. (0001534120) (Filer)